Back
ProQR Therapeutics NV Stock Price Chart
Unlock the power of "two-minute trades"
Learn how today!
Sell
1
PRQR
ProQR Therapeutics NV
Last Price:
$2.44
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.64 | Sell |
| 20-day SMA: | 2.73 | Sell |
| 50-day SMA: | 3.28 | Sell |
| 200-day SMA: | 2.33 | Buy |
| 8-day EMA: | 2.62 | Sell |
| 20-day EMA: | 2.79 | Sell |
| 50-day EMA: | 2.95 | Sell |
| 200-day EMA: | 2.5 | Sell |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 34.42 | Sell |
| Chaikin Money Flow: | -297376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 3.24) | Sell |
| Bollinger Bands (100): | (1.93 - 3.55) | Sell |
ProQR Therapeutics NV Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.42 while PRQR 8-day simple moving average is 2.64, which is a Sell signal.
-
The stock price of PRQR is 2.42 while ProQR Therapeutics NV 20-day SMA is 2.73, which makes it a Sell.
-
ProQR Therapeutics NV 50-day simple moving average is 3.28 while PRQR share price is 2.42, making it a Sell technically.
-
PRQR stock price is 2.42 and ProQR Therapeutics NV 200-day simple moving average is 2.33, creating a Buy signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
1
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a SellThe current ProQR Therapeutics NV [PRQR] share price is $2.42. The Score for PRQR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
256.3M
Price in USD:
2.42
Share Volume:
346.9K
ProQR Therapeutics NV 52-Week Range
52-Week High:
4.62
52-Week Low:
1.61
Sell
1
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?The ProQR Therapeutics NV stock price is 2.42 USD today.
-
Will PRQR stock go up or go down?ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators
-
Is ProQR Therapeutics NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.42 while PRQR 8-day exponential moving average is 2.62, which is a Sell signal.
-
The stock price of PRQR is 2.42 while ProQR Therapeutics NV 20-day EMA is 2.79, which makes it a Sell.
-
ProQR Therapeutics NV 50-day exponential moving average is 2.95 while PRQR share price is 2.42, making it a Sell technically.
-
PRQR stock price is 2.42 and ProQR Therapeutics NV 200-day simple moving average is 2.50, creating a Sell signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.03 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
-
PRQR Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting ProQR Therapeutics NV is a Sell
-
ProQR Therapeutics NV Relative Strength Index (RSI) is 34.42, which suggest ProQR Therapeutics NV is oversold
-
The Bollinger Bands (25) for ProQR Therapeutics NV is (2.52 - 3.24), which suggest ProQR Therapeutics NV is a Sell
-
The Bollinger Bands (100) for ProQR Therapeutics NV is (1.93 - 3.55), which suggest ProQR Therapeutics NV is a Sell
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.